vimarsana.com
Home
Live Updates
Achilles Therapeutics PLC: Achilles Therapeutics' New Immuno
Achilles Therapeutics PLC: Achilles Therapeutics' New Immuno
Achilles Therapeutics PLC: Achilles Therapeutics' New Immunogenicity Prediction Application of its AI-Powered PELEUS Platform Uniquely Identifies the Most Potent T Cell Antigens
- New AI module delivers a "Target-to-T cell" approach for revolutionizing the identification and prioritization of targets for personalized antigen approaches -LONDON, May 10, 2023 (GLOBE NEWSWIRE) --
Related Keywords
United Kingdom ,
London ,
City Of ,
Melissa Gardiner ,
Sukaina Virji ,
Mary Jane Elliott ,
Sergio Quezada ,
Bioinformatics Data Science Team At Achilles ,
Nasdaq ,
Cancer Research United Kingdom ,
National Institute Of Allergy ,
Achille Material Acquisition Program ,
Consilium Strategic Communications ,
Target Tot Cell ,
Chief Scientific Officer ,
Data Science Team ,
Operating Characteristic Area Under ,
Immune Epitope Database ,
National Institute ,
Infection Disease ,
Jane Elliott ,
Gefallene Big Techs ,
Achilles ,
Herapeutics ,
Immunogenicity ,
Prediction ,
Application ,
Owered ,
Seleus ,
Platform ,
Uniquely ,
Dentifies ,
Most ,
Kpotent ,
Fell ,
Antigens ,